Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2011

Feb 23, 2011

29777_dirs_2011-02-23_f01c242d-4dc0-4683-be43-a09e6a01dc9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-02-18

Reporting Person: Warmuth Michael J (Senior Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-18 Option (right to buy) $46.6 A 45800 Acquired 2021-02-17 Common shares (45800) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,267 on 02/18/2012, 15,266 on 02/18/2013, and 15,267 on 02/18/2014.